- Home
- AMBQ vs HQL Comparison
AMBQ vs HQL Comparison
Compare AMBQ & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBQ
- HQL
- Stock Information
- Founded
- AMBQ 2010
- HQL 1992
- Country
- AMBQ United States
- HQL United States
- Employees
- AMBQ N/A
- HQL N/A
- Industry
- AMBQ Semiconductors
- HQL Investment Managers
- Sector
- AMBQ Technology
- HQL Finance
- Exchange
- AMBQ Nasdaq
- HQL Nasdaq
- Market Cap
- AMBQ 451.6M
- HQL 440.3M
- IPO Year
- AMBQ 2025
- HQL N/A
- Fundamental
- Price
- AMBQ $24.81
- HQL $16.98
- Analyst Decision
- AMBQ Buy
- HQL
- Analyst Count
- AMBQ 4
- HQL 0
- Target Price
- AMBQ $41.75
- HQL N/A
- AVG Volume (30 Days)
- AMBQ 97.9K
- HQL 120.9K
- Earning Date
- AMBQ 11-06-2025
- HQL 01-01-0001
- Dividend Yield
- AMBQ N/A
- HQL 11.56%
- EPS Growth
- AMBQ N/A
- HQL N/A
- EPS
- AMBQ N/A
- HQL 0.79
- Revenue
- AMBQ $72,109,000.00
- HQL N/A
- Revenue This Year
- AMBQ N/A
- HQL N/A
- Revenue Next Year
- AMBQ $25.34
- HQL N/A
- P/E Ratio
- AMBQ N/A
- HQL $17.08
- Revenue Growth
- AMBQ 10.03
- HQL N/A
- 52 Week Low
- AMBQ $24.00
- HQL $11.34
- 52 Week High
- AMBQ $51.76
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- AMBQ N/A
- HQL 57.34
- Support Level
- AMBQ N/A
- HQL $16.51
- Resistance Level
- AMBQ N/A
- HQL $17.10
- Average True Range (ATR)
- AMBQ 0.00
- HQL 0.39
- MACD
- AMBQ 0.00
- HQL -0.06
- Stochastic Oscillator
- AMBQ 0.00
- HQL 60.66
About AMBQ Ambiq Micro Inc. Common Stock
Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute - especially at the edge.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.